Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013 / E7080)

Pediatrics

The main purpose of this study is to evaluate the antitumor activity and safety of Lenvatinib (MK-7902 / E7080) in children, adolescents, and young adults with relapsed or refractory solid malignancies after administration. Participants will be enrolled into initial tumor-specific cohorts which will be expanded based on observed response.
Pediatrics
II
Borinstein, Scott
NCT04447755
VICCPED2041

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: